Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). [electronic resource]
Producer: 20070119Description: 116-21 p. digitalISSN:- 1525-7304
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Combined Modality Therapy
- Disease Progression
- Docetaxel
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Southwestern United States
- Survival Analysis
- Survival Rate
- Taxoids -- adverse effects
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.